What We’re Reading: Expanding Monkeypox Vaccine Access; Annual COVID-19 Boosters; Juul to Pay in Teen Marketing Settlement

September 7th 2022, 2:24pm


Under a new contract with AmerisourceBergen Corp, HHS will expand access to monkeypox vaccines and treatments; as President Jow Biden encouraged Americans to receive their COVID-19 boosters this fall, the White House signaled toward annual COVID-19 boosters; Juul has reached a settlement with 37 states and Puerto Rico regarding the company’s marketing to teens.

Older Adults Benefit From High-Dose Influenza Vaccine

September 1st 2022, 7:16pm


A high-dose influenza vaccine reduces the risk of death and incidence of hospitalization for influenza and pneumonia among older adults.

Short-Course Antibiotic Therapy for Community-Acquired Pneumonia as Effective as Long-Course Therapy

August 28th 2022, 3:45pm


The real-world study adds to previous randomized controlled trial findings suggesting that shorter courses of antibiotic therapy can be sufficient for hospitalized patients with mild or moderate community-acquired pneumonia.

Pfizer Touts 85% Efficacy of RSV Vaccine for Adults, Will Seek FDA Approval

August 26th 2022, 2:25pm


In the phase 3 trial, Pfizer’s vaccine was 85.7% effective against respiratory syncytial virus (RSV) defined by 3 or more symptoms among older adults.

COVID-19 Is at Peak Infectiousness for 5 Days After Symptom Onset

August 18th 2022, 10:30pm


A recent cohort study found that two-thirds of patients could transmit SARS-CoV-2 at 5 days since their symptoms began; the median infectiousness duration in the sample was 5 days.

Frequent Productive Cough Associated With Worse Outcomes in Asthma, COPD

August 11th 2022, 8:20pm


Frequent productive cough was experienced by patients with asthma and/or chronic obstructive pulmonary disease (COPD), with symptom prevalence increasing with higher disease severity, according to the results of a recent study.

ILD Associated With Higher Risk of COVID-19 Severity, Mortality

August 9th 2022, 8:09pm


Interstitial lung disease (ILD) was shown to correlate with an increased risk of both COVID-19 severity and mortality, according to a recent meta-analysis.

Incidence, Mortality, Costs Increased Among Medicaid Patients With NVHAP

August 3rd 2022, 12:17pm


A recent study calculated the incidence and mortality rates for patients with Medicaid coverage who had nonventilator hospital-acquired pneumonia (NVHAP) and found possible associations between greater health care costs and NVHAP diagnosis.

Nutrition, Pneumonia Severity May Predict Life Expectancy From Aspiration Pneumonia

July 31st 2022, 12:35pm


Poor nutritional status and increased severity of pneumonia were associated with higher mortality rates among patients with aspiration pneumonia, according to a recent study.

Coughing Triggered by Mechanical Stimulation Suggests New Type of Cough Sensitization

July 28th 2022, 8:34pm


Mechanical stimulation, including finger pressure on discrete areas of the chest wall and neck, triggered reproducible coughing in about 50% of patients with chronic cough, indicating that chronic cough may be caused by the central convergence of somatic and visceral neural stimuli.